Chest

publication venue for

Progressive Dyspnea in a Woman With Tracheal Stenosis and Rheumatoid Arthritis. 2024
37-Year-Old Tracheostomized Woman With Overdistended Tracheostomy Cuff and Difficulty Ventilating. 2023
A 51-Year-Old Woman With Interstitial Lung Disease and Subsequent COVID-19 Presenting With Worsening Dyspnea. 2022
A 33-Year-Old Man With Chest Pain. 2022
A 29-Year-Old Man With Nonproductive Cough, Exertional Dyspnea, and Chest Discomfort. 2015
Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. 2014
Polymyxin use associated with respiratory arrest. 2012
Increasing dyspnea due to an anterior mediastinal mass. 2011
A 30-year-old man with a history of polysubstance abuse and hepatitis C presents with exertional dyspnea and patchy ground-glass opacities. 2006
Pulmonary smooth muscle proliferation occurring after lung transplantation. 1997
Familial association of primary pulmonary hypertension and a new low-oxygen affinity beta-chain hemoglobinopathy, Hb Washtenaw. 1996
The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. 1995
Dyspnea and tracheal mass in an elderly man. 1994
Dyspnea in a patient years after severe poliomyelitis. The role of cardiopulmonary exercise testing. 1994
Diagnosis of unilateral mainstem bronchial obstruction following single-lung transplantation with routine spirometry. 1993
Shoulder pain, pleural effusion, and positive antinuclear, antibodies in a man. 1992
Upper lobe cavitary mass in a steroid-dependent asthmatic patient. 1991
Intrathoracic lymphadenopathy. A rare manifestation of rheumatoid pulmonary disease. 1990
Esophageal cyst as a cause of chronic cough. 1984
Progressive swelling of abdomen and lower extremities with abnormal chest roentgenogram. 1977
Acute mercury vapor poisoning in the home. 1971
Fibrosing interstitial pneumonitis in ankylosing spondylitis. 1971
Intensive Care Unit Staffing in the United States. 2024
Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension. 2024
Comparison of Pirfenidone and Nintedanib: Post-Hoc Analysis of the CleanUP-IPF Study. 2023
Discrimination predicts suboptimal adherence to continuous positive airway pressure treatment and mediates Black-White differences in use. 2023
Cell-Free DNA Fragmentomes in the Diagnostic Evaluation of Patients With Symptoms Suggestive of Lung Cancer.. 164. 2023
Radiographic Lung Abnormalities in First-Degree Relatives of Patients with Different Subtypes of Pulmonary Fibrosis. 2023
New and Persistent Sedative Prescriptions Among Older Adults Following a Critical Illness: A Population-Based Cohort Study.. 163. 2023
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.. 163. 2022
Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort.. 163. 2022
Outpatient Mental Health Follow-up and Recurrent Self-harm and Suicide Among Patients Admitted to the ICU for Self-harm: A Population-based Cohort Study.. 163. 2022
Inhaled Nitric Oxide vs Epoprostenol During Acute Respiratory Failure: An Observational Target Trial Emulation.. 162. 2022
Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts.. 163. 2022
Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study.. 162. 2022
Cough-specific Quality of Life Predicts Disease Progression Among Patients with Interstitial Lung Disease: Data from the Pulmonary Fibrosis Foundation Patient Registry. 2022
Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy: A Cost-effectiveness Analysis.. 161. 2021
Significance of FEV₃/FEV₆ in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.. 161. 2021
Adiposity and Interstitial Lung Abnormalities in Community-Dwelling Adults: The MESA Cohort Study.. 160. 2021
Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19.. 160. 2021
Ratio of FEV₁/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.. 160. 2021
Portable Chest Radiography as an Exclusionary Test for Adverse Clinical Outcomes During the COVID-19 Pandemic.. 160. 2021
Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma.. 159. 2020
Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial.. 159. 2020
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.. 159. 2020
Fluid Response Evaluation in Sepsis Hypotension and Shock: A Randomized Clinical Trial.. 158. 2020
The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States.. 158. 2020
Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial.. 158. 2020
Associations of Serum Adipokines With Subclinical Interstitial Lung Disease Among Community-Dwelling Adults: The Multi-Ethnic Study of Atherosclerosis (MESA).. 157. 2019
Lung Cancer Screening CT: Sex-Specific Conversion Factors to Estimate Effective Radiation Dose From Dose-Length Product.. 156. 2019
Circulating Mitochondrial DNA as Predictor of Mortality in Critically Ill Patients: A Systematic Review of Clinical Studies.. 156. 2019
Objectively Measured Chronic Lung Injury on Chest CT.. 156. 2019
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.. 155. 2019
Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia.. 155. 2018
Rapidly Improving ARDS in Therapeutic Randomized Controlled Trials.. 155. 2018
Secondhand Exposure to Aerosols From Electronic Nicotine Delivery Systems and Asthma Exacerbations Among Youth With Asthma.. 155. 2018
Confronting the Challenge of COPD: What Is New in the Approaches to Diagnosis, Treatment, and Patient Outcomes.. 154. 2018
Focus on Idiopathic Pulmonary Fibrosis: Advancing Approaches to Diagnosis, Prognosis, and Treatment.. 154. 2018
Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory.. 155. 2018
Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD.. 154. 2018
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.. 153. 2017
Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters.. 153. 2017
Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD.. 152. 2017
Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.. 152. 2017
Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment.. 151. 2017
How Well Does CAPTURE Translate?: An Exploratory Analysis of a COPD Case-Finding Method for Spanish-Speaking Patients.. 152. 2017
Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia.. 151. 2017
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD.. 151. 2016
Pulmonary Hypertension Care Center Network: Improving Care and Outcomes in Pulmonary Hypertension.. 151. 2016
Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.. 150. 2016
Improving Quality of Acute Asthma Care in US Hospitals: Changes Between 1999-2000 and 2012-2013.. 150. 2016
Histopathology of Explanted Lungs From Patients With a Diagnosis of Pulmonary Sarcoidosis.. 149. 2016
Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline.. 149. 2016
Outcomes and Prognostic Features of Patients With Influenza Requiring Hospitalization and Receiving Early Antiviral Therapy: A Prospective Multicenter Cohort Study.. 149. 2016
Predictors of All-Cause Mortality in Patients With Severe COPD and Major Depression Admitted to a Rehabilitation Hospital.. 149. 2016
Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts.. 149. 2015
The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes.. 148. 2015
Patient Safety and Comparative Effectiveness of Anesthetic Technique in Open Lung Resections.. 148. 2015
Comparative effectiveness of robotic-assisted vs thoracoscopic lobectomy.. 146. 2014
Hospital-level variation in ICU admission and critical care procedures for patients hospitalized for pulmonary embolism.. 146. 2014
Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis.. 146. 2014
Prediction of acute respiratory disease in current and former smokers with and without COPD.. 146. 2014
Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism.. 145. 2014
Innovative designs for the smart ICU: Part 3: Advanced ICU informatics.. 145. 2014
Innovative Designs for the Smart ICU.. 145. 2014
Predicting pulmonary fibrosis disease course from past trends in pulmonary function.. 145. 2014
Temporal trends in the use of parenteral nutrition in critically ill patients.. 145. 2014
Innovative designs for the smart ICU: part 1: from initial thoughts to occupancy.. 145. 2014
Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.. 144. 2013
Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study.. 144. 2013
Is a strategy based on routine endotracheal cultures the best way to prescribe antibiotics in ventilator-associated pneumonia?. 144. 2013
Percent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies.. 144. 2013
Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.. 143. 2013
Validation of an interventional pulmonary examination.. 143. 2013
Efficacy of roflumilast in the COPD frequent exacerbator phenotype.. 143. 2013
A prognostic model for 6-month mortality in elderly survivors of critical illness.. 143. 2013
Barriers to optimal palliative care of lung transplant candidates.. 143. 2013
Optimizing the 6-min walk test as a measure of exercise capacity in COPD.. 142. 2012
Racial and ethnic differences in beliefs about lung cancer care.. 142. 2012
Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease.. 142. 2012
Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population.. 142. 2012
A national ICU telemedicine survey: validation and results.. 142. 2012
Is there a Starling curve for intensive care?. 141. 2012
Emphysema scores predict death from COPD and lung cancer.. 141. 2011
Racial differences in quality of life in patients with COPD.. 140. 2011
Impact of nonphysician staffing on outcomes in a medical ICU.. 139. 2011
Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial.. 139. 2010
Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals.. 138. 2010
Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.. 138. 2010
Bronchiolar disorders: a clinical-radiological diagnostic algorithm.. 137. 2010
High lung allocation score is associated with increased morbidity and mortality following transplantation.. 137. 2009
Antibiotic use in the management of pulmonary nodules.. 137. 2009
ICU admissions after actual or planned hospital discharge: incidence, clinical characteristics, and outcomes in patients with cancer.. 136. 2009
CT metrics of airway disease and emphysema in severe COPD.. 136. 2009
Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.. 137. 2009
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis.. 136. 2009
Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the human.. 135. 2009
Race/Ethnicity differences in the inpatient management of acute asthma in the United States.. 135. 2009
Serotonin transporter polymorphisms in patients with portopulmonary hypertension.. 135. 2009
Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD.. 135. 2008
Determinants of right ventricular ejection fraction in pulmonary arterial hypertension.. 135. 2008
Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial.. 134. 2008
Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury.. 134. 2008
Variability in small airway epithelial gene expression among normal smokers.. 133. 2008
Patient-reported and physician-reported depressive conditions in relation to asthma severity and control.. 133. 2008
Spirometry utilization for COPD: how do we measure up?. 132. 2007
Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores.. 132. 2007
Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens.. 131. 2007
Clinical application of tissue Doppler imaging in patients with idiopathic pulmonary hypertension.. 131. 2007
Increased COPD among HIV-positive compared to HIV-negative veterans.. 130. 2006
Trends in lung surgery: United States 1988 to 2002.. 130. 2006
Bronchodilator effect of infused B-type natriuretic peptide in asthma.. 130. 2006
Prevalence and mortality of acute lung injury and ARDS after lung resection.. 130. 2006
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia.. 129. 2006
Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer.. 129. 2006
CT screening for lung cancer: the value of short-term CT follow-up.. 129. 2006
Pulmonary function and abdominal adiposity in the general population.. 129. 2006
Randomized controlled trial of emergency department interventions to improve primary care follow-up for patients with acute asthma.. 129. 2006
Sex differences in the presentation and course of asthma hospitalizations.. 129. 2006
A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia.. 128. 2005
Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein.. 128. 2005
Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer.. 128. 2005
von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension.. 128. 2005
Thoracic radiation therapy and suitability of internal thoracic arteries for myocardial revascularization.. 128. 2005
Smoking and timing of cessation: impact on pulmonary complications after thoracotomy.. 127. 2005
Asthma exacerbations in North American adults: who are the "frequent fliers" in the emergency department?. 127. 2005
Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry.. 127. 2005
Choice of oximeter affects apnea-hypopnea index.. 127. 2005
Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis.. 127. 2005
Benchmarking lung cancer mortality rates in current and former smokers.. 126. 2004
Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975-2001.. 126. 2004
Mitral valve repair in patients with low left ventricular ejection fractions: early and late results.. 126. 2004
Surgical resection for lung cancer in the octogenarian.. 126. 2004
8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis.. 125. 2004
Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation.. 125. 2004
Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia.. 124. 2003
Tumor size predicts survival within stage IA non-small cell lung cancer.. 124. 2003
Acute asthma among adults presenting to the emergency department: the role of race/ethnicity and socioeconomic status.. 124. 2003
Body mass index and asthma severity among adults presenting to the emergency department.. 124. 2003
The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening.. 124. 2003
Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery.. 123. 2003
Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events.. 123. 2003
Cigarette smoking among asthmatic adults presenting to 64 emergency departments.. 123. 2003
Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry.. 123. 2003
Informal caregiving for chronic lung disease among older Americans.. 122. 2002
Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia.. 122. 2002
IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial.. 122. 2002
Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.. 121. 2002
Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions.. 121. 2002
D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients.. 121. 2002
Fiberoptic bronchoscopy in allogeneic bone marrow transplantation: findings in the era of serum cytomegalovirus antigen surveillance.. 120. 2001
Predicting mortality in patients suffering from prolonged critical illness: an assessment of four severity-of-illness measures.. 120. 2001
A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure.. 120. 2001
Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia.. 119. 2001
Diltiazem treatment does not alter renal function after thoracic surgery.. 119. 2001
Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states : 1993, 1995, and 1997.. 119. 2001
Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT.. 119. 2001
Pulmonary dysfunction in adults with nephropathic cystinosis.. 119. 2001
Three-dimensional CT-guided bronchoscopy with a real-time electromagnetic position sensor: a comparison of two image registration methods.. 118. 2000
Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids.. 117. 2000
Abnormal flow volume loops in patients with intrathoracic Hodgkin's disease.. 117. 2000
Acute exacerbation of COPD: factors associated with poor treatment outcome.. 117. 2000
Weight gain after lung volume reduction surgery is not correlated with improvement in pulmonary mechanics.. 116. 1999
Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia.. 116. 1999
Technology introduction in critical care: just knowing the price is not enough!. 116. 1999
The relation between physician experience and patterns of care for patients with AIDS-related Pneumocystis carinii pneumonia: results from a survey of 1,500 physicians in the United States.. 115. 1999
Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis.. 115. 1999
Can retrograde cardioplegia alone provide adequate protection for cardiac valve surgery?. 115. 1999
Real-time bronchoscope tip localization enables three-dimensional CT image guidance for transbronchial needle aspiration in swine.. 114. 1998
Use of balloon-expandable metallic stents in the management of bronchial stenosis and bronchomalacia after lung transplantation.. 114. 1998
Preoperative echocardiographic evaluation of patients referred for lung volume reduction surgery.. 114. 1998
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.. 113. 1998
Introduction: mechanisms and management of COPD: we can do better--it's time for a re-evaluation.. 113. 1998
Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy.. 113. 1998
Lung volume reduction surgery alters management of pulmonary nodules in patients with severe COPD.. 112. 1997
Quality control of spirometry testing in the registry for patients with severe alpha1-antitrypsin deficiency. alpha1-Antitrypsin Deficiency Registry Study Group.. 111. 1997
Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.. 111. 1997
Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group.. 111. 1997
High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea.. 111. 1997
A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy.. 110. 1996
Hemoptysis in HIV-infected patients.. 110. 1996
Relationship of early postoperative dysrhythmias and long-term outcome after resection of non-small cell lung cancer.. 110. 1996
Transthoracic needle aspiration in patients with severe emphysema. A study of lung transplant candidates.. 109. 1996
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.. 108. 1995
Inability of clinical history to distinguish primary snoring from obstructive sleep apnea syndrome in children.. 108. 1995
Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery.. 108. 1995
Preservation of adenosine 5'-triphosphate and mitochondrial function during hypercalcemic reperfusion using verapamil cardioplegia.. 107. 1995
Cardiopulmonary exercise testing following allogeneic lung transplantation for different underlying disease states.. 107. 1995
A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy.. 106. 1994
Should we reestablish the Lung Cancer Study Group?. 106. 1994
p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871.. 106. 1994
A registry of patients with severe deficiency of alpha 1-antitrypsin. Design and methods. The Alpha 1-Antitrypsin Deficiency Registry Study Group.. 106. 1994
Esophageal carcinoma with airway invasion. Evolution and choices of therapy.. 106. 1994
Association between reported use of inhaled triamcinolone and differential short-term responses to aerosolized albuterol in asthmatics in an emergency department setting.. 106. 1994
Pleurodesis using talc slurry.. 106. 1994
Should all patients undergoing cardiac catheterization or percutaneous transluminal coronary angioplasty receive oxygen?. 105. 1994
Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation.. 105. 1994
High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results.. 104. 1993
Aerosolization of superoxide dismutase. Augmentation of respiratory epithelial lining fluid antioxidant screen by aerosolization of recombinant human Cu++/Zn++ superoxide dismutase.. 104. 1993
Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression.. 104. 1993
Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease.. 104. 1993
Detection of deep venous thrombosis by magnetic resonance imaging.. 104. 1993
Intrathoracic adenopathy associated with pulmonary tuberculosis in patients with human immunodeficiency virus infection.. 103. 1993
Supported arm exercise vs unsupported arm exercise in the rehabilitation of patients with severe chronic airflow obstruction.. 103. 1993
Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma.. 103. 1993
Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis.. 103. 1993
High serum albuterol levels and tachycardia in adult asthmatics treated with high-dose continuously aerosolized albuterol.. 103. 1993
Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation.. 103. 1993
Pulmonary rehabilitation that includes arm exercise reduces metabolic and ventilatory requirements for simple arm elevation.. 103. 1993
Pediatric lung diseases. Task Force on Research and Education for the Prevention and Control of Respiratory Diseases.. 102. 1992
Reoperation, emergency and urgent open cardiac surgery in Jehovah's Witnesses.. 102. 1992
Respiratory response and ventilatory muscle recruitment during arm elevation in normal subjects.. 101. 1992
Bilateral bronchoalveolar lavage in the diagnosis of opportunistic pulmonary infections.. 100. 1991
Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes.. 100. 1991
Neutrophil-endothelial cell interaction in critical illness.. 99. 1991
Benefits of a multidisciplinary pulmonary rehabilitation program. Improvements are independent of lung function.. 99. 1991
Continual trending of Fick variables in the critically ill patient.. 99. 1991
Utility of fiberoptic bronchoscopy in nonresolving pneumonia.. 98. 1990
Clinical diagnosis of congestive heart failure in patients with acute dyspnea.. 97. 1990
Hypothyroidism. A reversible cause of diaphragmatic dysfunction.. 96. 1989
In-hospital cardiopulmonary resuscitation during asystole. Therapeutic factors associated with 24-hour survival.. 96. 1989
Patterns and routes of tracheobronchial colonization in mechanically ventilated patients. The role of nutritional status in colonization of the lower airway by Pseudomonas species.. 95. 1989
Immunohistochemical diagnosis of pulmonary eosinophilic granuloma on lung biopsy.. 94. 1988
Determinants of atrial natriuretic factor in the adult respiratory distress syndrome.. 94. 1988
T lymphocyte responses to mycobacterial antigen in AIDS patients with disseminated Mycobacterium avium-Mycobacterium intracellulare infection.. 93. 1988
The performance of four pleural drainage systems in an animal model of bronchopleural fistula.. 93. 1988
Alternans of the ST segment in variant angina. Incidence, time course and relation to ventricular arrhythmias during ambulatory electrocardiographic recording.. 93. 1988
Angiotensin converting enzyme in bronchoalveolar lavage in ARDS.. 91. 1987
Bronchoalveolar lavage. The report of an international conference.. 90. 1986
Pulmonary cell populations in the immunosuppressed patient. Bronchoalveolar lavage findings during episodes of pneumonitis.. 88. 1985
Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.. 87. 1985
Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome (AIDS). Diagnosis with bronchial brushings, biopsy, and bronchoalveolar lavage.. 87. 1985
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.. 87. 1985
Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids.. 86. 1984
Early prediction of outcome of respiratory failure. Comparison of high-frequency jet ventilation and volume-cycled ventilation.. 86. 1984
Respiratory infection complicating long-term tracheostomy. The implication of persistent gram-negative tracheobronchial colonization.. 85. 1984
A prospective study of complications of pulmonary artery catheterizations in 500 consecutive patients.. 84. 1983
Fibroblasts: important producers and targets of inflammatory prostaglandins in the lungs.. 83. 1983
Peripheral airways obstruction in idiopathic pulmonary artery hypertension (primary).. 83. 1983
Pulmonary oxygen toxicity. Bronchoalveolar lavage demonstration of early parameters of alveolitis.. 83. 1983
Role of fibronectin in fibrotic lung disease. A growth factor for human lung fibroblasts.. 83. 1983
Role of proteolytic and oxidative products of the neutrophil in determining the specificity of the pulmonary lesion in fibrotic and destructive lung disease.. 83. 1983
Left ventricular performance in the hypertensive patient. Exercise-mediated noninvasive separation of loading influences from intrinsic muscle dysfunction.. 83. 1983
Safety of fiberoptic bronchoalveolar lavage in evaluation of interstitial lung disease.. 80. 1981
Asbestos stimulates alveolar macrophages to release a factor causing human lung fibroblasts to replicate.. 80. 1981
Inflammation and asbestosis: characterization and maintenance of alveolitis following acute asbestos exposure.. 80. 1981
Pulmonary asbestosis and idiopathic pulmonary fibrosis: pathogenetic parallels.. 80. 1981
Pulmonary connective tissue and environmental lung disease.. 80. 1981
Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us?. 78. 1980
Danazol-induced elevation of serum alpha 1-antitrypsin in individuals with severe deficiency of this antiprotease.. 77. 1980
Mechanism by which cigarette smoke attracts polymorphonuclear leukocytes to lung.. 77. 1980
Exercise-induced ventricular tachycardia. Clinical features, relation to chronic ventricular ectopy, and prognosis.. 77. 1980
Comparison of the alveolitis of sarcoidosis and idiopathic pulmonary fibrosis.. 75. 1979
Pathogenetic studies in idiopathic pulmonary fibrosis. Control of neutrophil migration by immune complexes.. 75. 1979
Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume.. 74. 1978
Pulmonary resection in metastatic carcinoma.. 73. 1978
Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation.. 71. 1977
Biochemical approaches to the investigation of fibrotic lung disease.. 69. 1976
Diffuse fibrotic lung disease: a correlative study.. 69. 1976
Pulmonary mucormycosis with massive fatal hemoptysis.. 68. 1975
Collagen in the lung: development of a technology applicable to human lung disease.. 67. 1975
Fatal pulmonary infarction in a patient with sickle trait.. 64. 1973
Pneumomediastinum in diabetic ketoacidosis: comments on mechanism, incidence, and management.. 60. 1971
Cystic medionecrosis of the pulmonary arteries.. 57. 1970
Response.. 145. 2014
Airways disease presenting as restrictive impairment: a variant in asthma, a defining feature in world trade center lung disorder.. 144. 2013
Probiotics for prevention of ventilator-associated pneumonia.. 143. 2013
Prolonged grief disorder in the next of kin of adult patients who die during or after admission to intensive care.. 141. 2012
Longitudinal assessment of spirometry in World Trade Center responders.. 136. 2009
Nonpulmonary organ dysfunction and mortality with acute respiratory failure.. 134. 2008
Antibiotic use in acute exacerbations of chronic bronchitis.. 132. 2007
Corticosteroids in ARDS: a counterpoint.. 132. 2007
Sitaxsentan in pulmonary arterial hypertension.. 123. 2003
Bacteria and COPD exacerbations redux.. 119. 2001
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.. 118. 2000
Hormone replacement therapy: a possible risk factor in carriers of familial primary pulmonary hypertension.. 116. 1999
Scoring organ dysfunction.. 114. 1998
Final measurements vs ANOVA for data analysis.. 114. 1998
Benefits of a multidisciplinary pulmonary rehabilitation program.. 105. 1994
Bilateral upper extremity blood pressure measurements should be routine prior to coronary artery surgery.. 101. 1992
Alpha 1-antitrypsin deficiency registry.. 97. 1990
Management of acute exacerbations of COPD: a summary and appraisal of published evidence. 2001
Response. 2023
A Molecular Classifier That Identifies Usual Interstitial Pneumonia in Transbronchial Biopsy Specimens of Patients With Interstitial Lung Disease. 2020
Response. 2018
Response. 2014
Response. 2013
The unresponsive asthmatic. Misuse of a spacer system. 1992
Diagnosing Pneumocystis carinii. 1987
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. 2015
POINT: Does Normothermic Regional Perfusion Violate the Ethical Principles Underlying Organ Procurement? Yes.. 162. 2022
Rebuttal From Dr DeCamp et al.. 162. 2022
Variation in Strategies to Increase Critical Care Services During the COVID-19 Pandemic.. 160. 2021
Decision-making About Risk in the Era of the Novel Coronavirus Disease.. 158. 2020
When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic.. 158. 2020
POINT: Can Screening for COPD Improve Outcomes? Yes.. 157. 2020
Rebuttal From Drs Yawn and Martinez.. 157. 2020
Clinical Impact of Antimicrobial Resistance: Using New Tools to Answer Old Questions.. 155. 2019
Time to Understand the Infrequency of the Frequent Exacerbator Phenotype in COPD.. 153. 2018
Imaging for the Management of Community-Acquired Pneumonia: What to Do if the Chest Radiograph Is Clear.. 153. 2018
POINT: Is ICD-10 Diagnosis Coding Important in the Era of Big Data? Yes.. 153. 2018
Rebuttal From Dr Weiner.. 153. 2018
Burnout Syndrome in ICU Caregivers: Time to Extinguish!. 150. 2016
There Is No Such Thing as a "Positive" Antibody Test: Diagnosing Heparin-Induced Thrombocytopenia in 2015.. 148. 2015
Lymph nodes in lung cancer: location, location, and location?. 147. 2015
The complexities of ICU discharge.. 147. 2015
Managing ventilator complications in a "VACuum" of data.. 147. 2015
Preparing for the unexpected: lessons learned about respiratory infection from the Japanese tsunami of 2011.. 143. 2013
From telemedicine to a critical care database: a new resource for national benchmarking.. 140. 2011
Viral community-acquired pneumonia: if we do not diagnose it and do not treat it, can it still hurt us?. 138. 2010
The perception gap: race, religion, and prognosis in the ICU.. 138. 2010
Fighting vampires and ventilator-associated pneumonia: is silver the magic bullet?. 137. 2010
The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis.. 131. 2007
Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.. 131. 2007
Health-care-associated pneumonia: a new therapeutic paradigm.. 128. 2005
What is the prognosis for using the pneumonia severity index to make site-of-care decisions in community-acquired pneumonia?. 124. 2003
Follow-up of patients with completely resected lung cancer.. 115. 1999
Women, smoking, and lung cancer.. 113. 1998
Respiratory infections. An opportunity for integrated disease management.. 109. 1996
The optimal treatment of malignant pleural effusions. A continuing dilemma.. 100. 1991
The eosinophil in idiopathic pulmonary fibrosis.. 92. 1987
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies. 2020
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype. 2020
Cavitary Lung Diseases: A Clinical-Radiologic Algorithmic Approach. 2018
Cystic Lung Diseases: Algorithmic Approach. 2016
The emerging importance of autophagy in pulmonary diseases. 2012
Management of pneumonia in the nursing home. 2010
Severe hypoxemic respiratory failure: part 1--ventilatory strategies. 2010
Diagnosis and treatment of rhinovirus respiratory infections. 2003
Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. 2002
The role of thrombin and thrombin inhibitors in coronary angioplasty. 1995
Response of the lower respiratory tract to injury. Mechanisms of repair of the parenchymal cells of the alveolar wall. 1983
Diseases Involving the Lung Peribronchovascular Region: a CT-Pathologic Classification. 2024
Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene. 2020
Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis. 2020
Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation: An Expert Panel Report of the Task Force for Mass Critical Care and the American College of Chest Physicians. 2020
An Algorithmic Approach to the Interpretation of Diffuse Lung Disease on Chest CT Imaging: A Theory of Almost Everything. 2019
Lung Hyperlucency: A Clinical-Radiologic Algorithmic Approach to Diagnosis. 2019
Clinical Approach to the Therapy of Asthma-COPD Overlap. 2018
Low-Dose CT Scan for Lung Cancer Screening: Clinical and Coding Considerations. 2017
Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. 2011
Acute exacerbation of idiopathic pulmonary fibrosis. 2007
Recent advances in idiopathic pulmonary fibrosis. 2007
Screening for lung cancer: a review of the current literature. 2003
Antithrombotic therapy in patients undergoing percutaneous coronary intervention. 2001
Intravenous thrombolysis in acute myocardial infarction. 2001
Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. 2001
Evolving concepts regarding selection of patients for cardiac transplantation. Assessing risks and benefits. 1996
Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. 1994
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. 2013
Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). 2008
Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). 2008
Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). 2008
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). 2008
Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). 2007
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. 2004
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. 2004
Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. 2004
Screening for lung cancer: the guidelines. 2003
The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part 1. 2001

VIVO Weill Cornell Medical College

Chest Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)